why is there a glp 1 shortage How Markets Solved the GLP-1 How GLP-1s Broke Healthcare Distribution

adults are considered obese, and with traditional weight loss strategies like diet and exercise proving insufficient for many, physicians are increasingly turning to medication as an adjunct treatment

However, certain warning signs should prompt discontinuation

Steady dose escalation to higher doses than for glycaemic control are indicated if: BMI is 30 kg/m 2 , or BMI 27 to 30 kg/m 2 , and for the range 2730 kg/m 2 if there is one weight-related comorbidity (hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea, prediabetes or T2D

160 TsengC

If you have significant weight loss goals or a BMI of 30 or higher, our Medical Weight Loss Program may be a better fit